UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the period ended March 28,September 26, 2020
or
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to
Commission file number 0-16088
CPS TECHNOLOGIES CORP.CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware | 04-2832509 | |
(State or Other Jurisdiction of Incorporation or Organization) |
| (I.R.S. Employer Identification No.) |
111 South Worcester Street | ||
Norton, MA | 02766-2102 | |
(Address of principal executive offices) |
| (Zip Code) |
(508) 222-0614
Registrant’sRegistrants Telephone Number, including Area Code:
CPS TECHNOLOGIES CORP.Technologies Corporation
111 South Worcester Street
Norton, MA 02766-2102
Former Name, Former Address and Former Fiscal Year if Changed since Last Report
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period than the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. [X] Yes [ ] No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X ][X] Yes [ ] No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smallersmaller reporting company,” and “emerging growth company”” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [X] Smaller reporting company [X]
Emerging growth company[ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act):
[ ] Yes [X] No
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value CPSH NASDAQ Capital Markets
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. Number of shares of common stock outstanding as of May 8,October 30, 2020: 13,207,436.13,296,168.
PART I FINANCIAL INFORMATION
ITEM 1 FINANCIAL STATEMENTS (Unaudited)
CPS TECHNOLOGIES CORPORATION
Balance Sheets (Unaudited)
(continued on next page)
September 26, | December 28, | |||||||
2020 | 2019 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 112,575 | $ | 133,965 | ||||
Accounts receivable-trade, net | 3,961,606 | 4,086,945 | ||||||
Inventories, net | 4,187,272 | 3,099,824 | ||||||
Prepaid expenses and other current assets | 173,583 | 147,786 | ||||||
Total current assets | 8,435,036 | 7,468,520 | ||||||
Property and equipment: | ||||||||
Production equipment | 10,282,980 | 9,649,169 | ||||||
Furniture and office equipment | 508,423 | 508,423 | ||||||
Leasehold improvements | 934,195 | 934,195 | ||||||
Total cost | 11,725,598 | 11,091,787 | ||||||
Accumulated depreciation and amortization | (10,478,054) | (10,110,663) | ||||||
Construction in progress | 127,408 | 255,754 | ||||||
Net property and equipment | 1,374,952 | 1,236,878 | ||||||
Right-of-use lease asset | 63,000 | 171,000 | ||||||
Deferred taxes, net | 114,253 | 147,873 | ||||||
Total assets | $ | 9,987,241 | $ | 9,024,271 |
See accompanying notes to financial statements.
CPS TECHNOLOGIES CORP.
CORPORATION
Balance Sheets (Unaudited)
(concluded)
March 28, | December 28, | |||||||
2020 | 2019 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 122,255 | $ | 133,965 | ||||
Accounts receivable-trade, net | 5,959,224 | 4,086,945 | ||||||
Inventories, net | 3,595,338 | 3,099,824 | ||||||
Prepaid expenses and other current assets | 227,459 | 147,786 | ||||||
Total current assets | 9,904,276 | 7,468,520 | ||||||
Property and equipment: | ||||||||
Production equipment | 9,919,484 | 9,649,169 | ||||||
Furniture and office equipment | 508,423 | 508,423 | ||||||
Leasehold improvements | 934,195 | 934,195 | ||||||
Total cost | 11,362,102 | 11,091,787 | ||||||
Accumulated depreciation and amortization | (10,224,691) | (10,110,663) | ||||||
Construction in progress | 286,891 | 255,754 | ||||||
Net property and equipment | 1,424,302 | 1,236,878 | ||||||
Right-of-use lease asset | 136,000 | 171,000 | ||||||
Deferred taxes, net | 147,873 | 147,873 | ||||||
Total Assets | $ | 11,612,451 | $ | 9,024,271 |
September 26, | December 28, | |||||||
2020 | 2019 | |||||||
LIABILITIES AND STOCKHOLDERS` EQUITY | ||||||||
Current liabilities: | ||||||||
Borrowings against line of credit | 835,123 | 1,249,588 | ||||||
Note payable, current portion | 55,795 | — | ||||||
Accounts payable | 1,221,642 | 1,436,417 | ||||||
Accrued expenses | 720,182 | 815,166 | ||||||
Deferred revenue | 358,000 | 21,110 | ||||||
Lease liability, current portion | 63,000 | 148,000 | ||||||
Total current liabilities | 3,253,742 | 3,670,281 | ||||||
Note payable less current portion | 169,388 | — | ||||||
Long term lease liability | — | 23,000 | ||||||
Total liabilities | 3,423,130 | 3,693,281 | ||||||
Commitments (note 4) | ||||||||
Stockholders` equity: | ||||||||
Common stock, $0.01 par value, | ||||||||
authorized 20,000,000 shares; | ||||||||
issued 13,716,242 and 13,427,492, respectively; | ||||||||
outstanding 13,296,168 and 13,207,436, respectively; | ||||||||
at September 26, 2020 and December 28, 2019; | 137,162 | 134,275 | ||||||
Additional paid-in capital | 36,633,556 | 36,094,201 | ||||||
Accumulated deficit | (29,248,532) | (30,380,433) | ||||||
Less cost of 420,074 and 220,056 common shares | ||||||||
repurchased, respectively; | ||||||||
at September 26, 2020 and December 28, 2019 | (958,075) | (517,053) | ||||||
Total stockholders` equity | 6,564,111 | 5,330,990 | ||||||
Total liabilities and stockholders` | ||||||||
equity | $ | 9,987,241 | $ | 9,024,271 |
See accompanying notes to financial statements.
(continued)
CPS TECHNOLOGIES CORP.CORPORATION
Statements of Operations (Unaudited)
Balance Sheets (Unaudited)
(concluded)
March 28, | December 28, | |||||||
2020 | 2019 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Borrowings against line of credit | 1,577,506 | 1,249,588 | ||||||
Note payable, current portion | 45,980 | — | ||||||
Accounts payable | 2,621,862 | 1,436,417 | ||||||
Accrued expenses | 691,921 | 815,166 | ||||||
Deferred revenue | 381,216 | 21,110 | ||||||
Lease liability, current portion | 136,000 | 148,000 | ||||||
Total current liabilities | 5,454,485 | 3,670,281 | ||||||
Note payable less current portion | 159,649 | — | ||||||
Long term lease liability | — | 23,000 | ||||||
Total liabilities | 5,614,134 | 3,693,281 | ||||||
Commitments (note 4) | ||||||||
Stockholders’ equity: | ||||||||
Common stock, $0.01 par value, | ||||||||
authorized 20,000,000 shares; | ||||||||
issued 13,427,492 shares; | ||||||||
outstanding 13,207,436 shares; | ||||||||
at March 28, 2020 and December 28, 2019, respectively | 134,275 | 134,275 | ||||||
Additional paid-in capital | 36,159,874 | 36,094,201 | ||||||
Accumulated deficit | (29,778,779) | (30,380,433) | ||||||
Less cost of 220,056 common shares repurchased | ||||||||
at March 28, 2020 and December 28, 2019, | (517,053) | (517,053) | ||||||
Total stockholders’ equity | 5,998,317 | 5,330,990 | ||||||
Total liabilities and stockholders’ | ||||||||
equity | $ | 11,612,451 | $ | 9,024,271 | ||||
Fiscal Quarters Ended | Nine Months Ended | |||||||||||||||
September 26, | September 28, | September 26, | September 28, | |||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Revenues: | ||||||||||||||||
Product sales | $ | 4,452,387 | $ | 4,387,125 | $ | 16,721,973 | $ | 16,023,615 | ||||||||
Total Revenues | 4,452,387 | 4,387,125 | 16,721,973 | 16,023,615 | ||||||||||||
Cost of product sales | 3,514,813 | 4,164,187 | 13,050,860 | 14,466,266 | ||||||||||||
Gross Margin | 937,574 | 222,938 | 3,671,113 | 1,557,349 | ||||||||||||
Selling, general and | ||||||||||||||||
administrative expense | 684,836 | 702,413 | 2,466,198 | 2,523,178 | ||||||||||||
Operating income (loss) | 252,738 | (479,475) | 1,204,915 | (965,829) | ||||||||||||
Interest income (expense), net | (21,263) | (16,495) | (87,004 | ) | (23,757) | |||||||||||
Other income (expense), net | (3) | — | 14,446 | — | ||||||||||||
Net income (loss) before income | ||||||||||||||||
tax expense | 231,472 | (495,970) | 1,132,357 | (989,586) | ||||||||||||
Income tax provision | 456 | — | 456 | — | ||||||||||||
Net income (loss) | $ | 231,016 | $ | (495,970) | $ | 1,131,901 | $ | (989,586) | ||||||||
Net income (loss) per | ||||||||||||||||
basic common share | $ | 0.02 | $ | (0.04) | $ | 0.09 | $ | (0.07) | ||||||||
Weighted average number of | ||||||||||||||||
basic common shares | ||||||||||||||||
outstanding | 13,288,652 | 13,206,069 | 13,234,508 | 13,206,984 | ||||||||||||
Net income (loss) per | ||||||||||||||||
diluted common share | $ | 0.02 | $ | (0.04) | $ | 0.09 | $ | (0.07) | ||||||||
Weighted average number of | ||||||||||||||||
diluted common shares | ||||||||||||||||
outstanding | 13,456,486 | 13,206,069 | 13,320,915 | 13,206,984 |
See accompanying notes to financial statements.
CPS TECHNOLOGIES CORP.
Statements of Operations (Unaudited)
Fiscal Quarters Ended | ||||||||
March 28, | March 30, | |||||||
2020 | 2019 | |||||||
Revenues: | ||||||||
Product sales | $ | 6,511,571 | $ | 5,269,538 | ||||
Total revenues | 6,511,571 | 5,269,538 | ||||||
Cost of product sales | 4,961,361 | 5,110,114 | ||||||
Gross Margin | 1,550,210 | 159,424 | ||||||
Selling, general, and | ||||||||
administrative expense | 928,590 | 903,686 | ||||||
Income (loss) from operations | 621,620 | (744,262) | ||||||
Other income (expense), net | (19,966) | 48 | ||||||
Income (loss) before taxes | 601,654 | (744,214) | ||||||
Income tax provision (benefit) | — | — | ||||||
Net income (loss) | $ | 601,654 | $ | (744,214) | ||||
Net income (loss) per | ||||||||
basic common share | $ | 0.05 | $ | (0.06) | ||||
Weighted average number of | ||||||||
basic common shares | ||||||||
outstanding | 13,207,436 | 13,206,069 | ||||||
Net income (loss) per | ||||||||
diluted common share | $ | 0.05 | $ | (0.06) | ||||
Weighted average number of | ||||||||
diluted common shares | ||||||||
outstanding | 13,247,131 | 13,206,069 | ||||||
See accompanying notes to financial statements.
CPS TECHNOLOGIES CORPORATION
STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND NINE MONTHS ENDED MARCH 28,SEPTEMBER 26, 2020 AND MARCH 30,SEPTEMBER 28, 2019
Common Stock | ||||||||||||||||||||||||
Number of | Additional | Total | ||||||||||||||||||||||
shares | Par | paid-in | Accumulated | Stock | stockholders’ | |||||||||||||||||||
issued | Value | capital | deficit | repurchased | equity | |||||||||||||||||||
Balance at December 28, 2019 | 13,427,492 | $ | 134,275 | $ | 36,094,201 | (30,380,433) | (517,053) | 5,330,990 | ||||||||||||||||
Share-based compensation expense | — | — | 65,673 | — | — | 65,673 | ||||||||||||||||||
Net income (loss) | 601,654 | — | 601,654 | |||||||||||||||||||||
Balance at March 28, 2020 | 13,427,492 | 134,275 | 36,159,874 | (29,778,779) | (517,053) | 5,998,317 | ||||||||||||||||||
Balance at December 29, 2018 | 13,425,992 | $ | 134,260 | $ | 35,960,545 | (29,742,231) | (517,053) | 5,835,521 | ||||||||||||||||
Share-based compensation expense | — | — | 58,986 | — | — | 58,986 | ||||||||||||||||||
Issuance of common stock | 1,500 | 15 | 2,235 | — | — | 2,250 | ||||||||||||||||||
Net income (loss) | (744,214) | — | (744,214) | |||||||||||||||||||||
Balance at March 30, 2019 | 13,427,492 | 134,275 | 36,021,766 | (30,486,445) | (517,053) | 5,152,543 |
Common Stock | |||||||||||||||||||||||
Number of | Additional | Total | |||||||||||||||||||||
shares | Par | paid-in | Accumulated | Stock | stockholders’ | ||||||||||||||||||
issued | Value | capital | deficit | repurchased | equity | ||||||||||||||||||
Balance at June 27, 2020 | 13,427,492 | $ | 134,275 | $ | 36,177,264 | (29,479,548) | (517,053) | 6,314,938 | |||||||||||||||
Share-based compensation expense | — | — | 17,389 | — | — | 17,389 | |||||||||||||||||
Issuance of common stock | 500 | 5 | 763 | -- | -- | 768 | |||||||||||||||||
Employee option exercises | 288,250 | 2,882 | 438,140 | -- | (441,022) | -- | |||||||||||||||||
Net income | -- | -- | -- | 231,016 | — | 231,016 | |||||||||||||||||
Balance at September 26, 2020 | 13,716,242 | 137,162 | 36,633,556 | (29,248,532) | (958,075) | 6,564,111 | |||||||||||||||||
Common Stock | ||||||||||||||||||||||||
Number of | Additional | Total | ||||||||||||||||||||||
shares | Par | paid-in | Accumulated | Stock | stockholders’ | |||||||||||||||||||
issued | Value | capital | deficit | repurchased | equity | |||||||||||||||||||
Balance at December 28, 2019 | 13,427,492 | $ | 134,275 | $ | 36,094,201 | (30,380,433) | (517,053) | 5,330,990 | ||||||||||||||||
Share-based compensation expense | — | — | 100,452 | — | — | 100,452 | ||||||||||||||||||
Issuance of common stock | 500 | 5 | 763 | -- | -- | 768 | ||||||||||||||||||
Employee option exercises | 288,250 | 2,882 | 438,140 | — | (441,022) | -- | ||||||||||||||||||
Net income | — | — | — | 1,131,901 | — | 1,131,901 | ||||||||||||||||||
Balance at September 26, 2020 | 13,716,242 | 137,162 | 36,633,556 | (29,248,532) | (958,075) | 6,564,111 |
Common Stock | ||||||||||||||||||||||||
Number of | Additional | Total | ||||||||||||||||||||||
shares | Par | paid-in | Accumulated | Stock | stockholders’ | |||||||||||||||||||
issued | Value | capital | deficit | repurchased | equity | |||||||||||||||||||
Balance at June 29, 2019 | 13,427,492 | $ | 134,275 | $ | 36,048,177 | (30,235,847) | (517,053) | 5,429,552 | ||||||||||||||||
Share-based compensation expense | — | — | 28,000 | — | — | 28,000 | ||||||||||||||||||
Net (loss) | — | — | — | (495,970) | — | (495,970) | ||||||||||||||||||
Balance at September 28, 2019 | 13,427,492 | 134,275 | 36,076,177 | (30,731,817) | (517,053) | 4,961,582 |
Common Stock | ||||||||||||||||||||||||
Number of | Additional | Total | ||||||||||||||||||||||
shares | Par | paid-in | Accumulated | Stock | stockholders’ | |||||||||||||||||||
issued | Value | capital | deficit | repurchased | equity | |||||||||||||||||||
Balance at December 29, 2018 | 13,425,992 | $ | 134,260 | $ | 35,960,545 | (29,742,231) | (517,053) | 5,835,521 | ||||||||||||||||
Share-based compensation expense | — | — | 113,397 | — | — | 113,397 | ||||||||||||||||||
Issuance of common stock | 1,500 | 15 | 2,235 | — | — | 2,250 | ||||||||||||||||||
Net (loss) | — | — | — | (989,586) | — | (989,586) | ||||||||||||||||||
Balance at September 28, 2019 | 13,427,492 | 134,275 | 36,076,177 | (30,731,817) | (517,053) | 4,961,582 |
See accompanying notes to financial statements.
CPS TECHNOLOGIES CORP.
CORPORATION
Statements of Cash Flows (Unaudited)
Fiscal Quarters Ended | ||||||||||||||||
March 28, | March 30, | Nine Month Periods Ended | ||||||||||||||
2020 | 2019 | September 26, | September 28, | |||||||||||||
2020 | 2019 | |||||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income (loss) | $ | 601,654 | $ | (744,214) | ||||||||||||
Net income | $ | 1,131,901 | $ | (989,586) | ||||||||||||
Adjustments to reconcile net income (loss) | ||||||||||||||||
to cash used in operating activities: | ||||||||||||||||
Depreciation and amortization | 128,759 | 139,465 | ||||||||||||||
to cash provided by (used in) operating activities | ||||||||||||||||
Depreciation & amortization | 382,121 | 391,156 | ||||||||||||||
Share-based compensation | 65,673 | 61,236 | 100,452 | 115,647 | ||||||||||||
Deferred taxes | 33,620 | — | ||||||||||||||
Gain on sale of property and equipment | (5,000) | — | (5,000) | — | ||||||||||||
Changes in: | ||||||||||||||||
Accounts receivable-trade | (1,872,279) | (138,667) | 125,339 | 257,348 | ||||||||||||
Inventories | (495,514) | 115,342 | (1,087,448) | 401,822 | ||||||||||||
Prepaid expenses and other current assets | (79,673) | (47,209) | ||||||||||||||
Prepaid expenses | (25,797) | (16,982) | ||||||||||||||
Accounts payable | 1,185,445 | 388,619 | (214,775) | (206,204) | ||||||||||||
Deferred revenue | 336,890 | — | ||||||||||||||
Accrued expenses | (123,245) | (255,980) | (94,984) | (274,325) | ||||||||||||
Deferred revenue | 360,106 | — | ||||||||||||||
Net cash used in operating activities | (234,074) | (481,408) | ||||||||||||||
Net cash provided by (used in) operating | ||||||||||||||||
activities | 682,319 | (321,124) | ||||||||||||||
Cash flows from investing activities: | ||||||||||||||||
Purchases of property and equipment | (107,600) | (116,327) | (285,909) | (250,128) | ||||||||||||
Proceeds from sale of property and equipment | 5,000 | — | 5,000 | — | ||||||||||||
Net cash used in investing | ||||||||||||||||
Net cash provided by (used in) investing | ||||||||||||||||
activities | (102,600) | (116,327) | (280,909) | (250,128) | ||||||||||||
Cash flows from financing activities: | ||||||||||||||||
Net borrowings on line of credit | 327,918 | 200,000 | (414,465) | 412,732 | ||||||||||||
Proceeds from employee stock options | 768 | — | ||||||||||||||
Payments on note payable | (2,954) | — | (9,103) | — | ||||||||||||
Net cash provided by | ||||||||||||||||
Net cash provided by (used in) | ||||||||||||||||
financing activities | 324,964 | 200,000 | (422,800) | 412,732 | ||||||||||||
Net decrease in cash and cash equivalents | (11,710) | (397,735) | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | (21,390) | (158,520) | ||||||||||||||
Cash and cash equivalents at beginning of period | 133,965 | 628,804 | 133,965 | 628,804 | ||||||||||||
Cash and cash equivalents at end of period | $ | 122,255 | $ | 231,069 | $ | 112,575 | $ | 470,284 | ||||||||
Supplemental disclosures of cash flows information: | ||||||||||||||||
Cash paid for income taxes | $ | — | $ | 485 | ||||||||||||
Cash paid for interest | $ | 33,216 | $ | — | $ | 87,004 | $ | — | ||||||||
Supplemental disclosures of non-cash activity: | ||||||||||||||||
Issuance of note payable to finance equipment purchase | $ | 208,583 | $ | — | ||||||||||||
Net exercise of stock options | $ | 441,022 | $ | -- | ||||||||||||
Issuance of long term debt to finance equipment purchases | $ | 247,807 | $ | -- |
See accompanying notes to financial statements.
CPS TECHNOLOGIES CORP.
CORPORATION
Notes to Financial Statement
Statements
(Unaudited)
(1) Nature of Business
CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive and other industries. The Company’s primary advanced material solution is metal-matrix composites (MMC’s) which are a combination of metal and ceramic.
CPS also assembles housings and packages for hybrid circuits. These housings and packages may include components made of metal-matrix composites or they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.
The Company sells into several end markets including the wireless communications infrastructure market, high-performance microprocessor market, motor controller market, and other microelectronic and structural markets.
(2) Summary of Significant Accounting Policies
As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles.
The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.
The Company’s balance sheet at December 28, 2019 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.
For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form 10-K for the year ended December 28, 2019 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.alsic.com.
The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.
(3) Net Income (Loss)(loss) Per Common and Common Equivalent Share
Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive.
The following table presents the calculation of both basic and diluted EPS:
Three Months Ended | Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
March 28, | March 30, | September 26, | September 28, | September 26, | September 28, | |||||||||||||||||||
2020 | 2019 | 2020 | 2019 | 2020 | 2019 | |||||||||||||||||||
Basic EPS Computation: | ||||||||||||||||||||||||
Numerator: | ||||||||||||||||||||||||
Net income (loss) | $ | 601,654 | $ | (744,214) | $ | 231,016 | $ | (495,970) | $ | 1,131,901 | $ | (989,586) | ||||||||||||
Denominator: | ||||||||||||||||||||||||
Weighted average | ||||||||||||||||||||||||
Common shares | ||||||||||||||||||||||||
Outstanding | 13,207,436 | 13,206,069 | 13,288,652 | 13,206,069 | 13,234,508 | 13,206,984 | ||||||||||||||||||
Basic EPS | $ | 0.05 | $ | (0.06) | $ | 0.02 | $ | (0.04) | $ | 0.09 | $ | (0.07) | ||||||||||||
Diluted EPS Computation: | ||||||||||||||||||||||||
Numerator: | ||||||||||||||||||||||||
Net income (loss) | $ | 601,654 | $ | (744,214) | $ | 231,016 | $ | (495,970) | $ | 1,131,901 | $ | (989,586) | ||||||||||||
Denominator: | ||||||||||||||||||||||||
Weighted average | ||||||||||||||||||||||||
Common shares | ||||||||||||||||||||||||
Outstanding | 13,207,436 | 13,206,069 | 13,288,652 | 13,206,069 | 13,234,508 | 13,206,984 | ||||||||||||||||||
Dilutive effect of stock options | 39,695 | — | 167,834 | — | 87,217 | — | ||||||||||||||||||
Total Shares | 13,247,131 | 13,206,069 | 13,456,486 | 13,206,069 | 13,320,915 | 13,206,984 | ||||||||||||||||||
Diluted EPS | $ | 0.05 | $ | (0.06) | $ | 0.02 | $ | (0.04) | $ | 0.09 | $ | (0.07) | ||||||||||||
(4) Commitments & Contingencies
Commitments
Leases
The Company has two real estate leases—one expiring in February 2021 and one with an 11 month duration with options to extend additional years. Since theexpiring December 2020. The latter is not reasonably certain that any options willexpected to be exercised, itrenewed and has not been recorded on the balance sheet.sheet in accordance with Accounting Standards Codification (ASC) 842 for leases. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these have been capitalized.
The lease expiring in 2021 (the “Norton facility lease’) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized on December 30, 2018 based on the present value of remaining lease payments over the remaining lease term using the Company’s incremental borrowing rate at commencement dates.date of adoption. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Operating Leases
Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense is includedallocated between Cost of Product Sales and Selling, General and Administrative Expense in rents on the statements of operations and is reported net of lease income. Lease income is not material to the results of operations for the quarter ended March 28, 2020.statement
The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating leases as of March 28,September 26, 2020
(Dollars in Thousands) | March 28, 2020 | |||
Maturity of capitalized lease liabilities | Lease payments | |||
2020 | 117 | |||
2021 | 26 | |||
Total undiscounted operating lease payments | $ | 143 | ||
Less: Imputed interest | (7) | |||
Present value of operating lease liability | $ | 136 |
(Dollars in Thousands) | Sept 26, 2020 | |||
Maturity of capitalized lease liabilities | Lease payments | |||
2020 (remaining) | 39 | |||
2021 | 26 | |||
Total undiscounted operating lease payments | $ | 65 | ||
Less: Imputed interest | (2) | |||
Present value of operating lease liability | $ | 63 |
Balance Sheet Classification | ||||||||
Current lease liability | $ | 136 | $ | 63 | ||||
Long-term lease liability | 0 | — | ||||||
Total operating lease liability | $ | 136 | $ | 63 | ||||
Other Information | ||||||||
Weighted-average remaining lease term for capitalized operating leases | 11 months | 5 months | ||||||
Weighted-average discount rate for capitalized operating leases | 6.5% | 6.5% | ||||||
Cash Flows
An initial right-of-use asset of $310 thousand was recognized as a non-cash asset addition with the adoption of the new lease accounting standard on December 30, 2018. Cash paid for the amounts included in the present value of operating lease liabilities was $114 thousand during the first nine months of 2020 and is included in operating cash flows.
Operating Lease Costs and Cash Flows
Operating lease cost and cash paid was $38$114 thousand during the first quarternine months of 2020. This cost is related to its long-term operating lease. All other short-term leases were immaterial.
Finance Leases
The company does not have any finance leases.
(5) Share-Based Payments
The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.
During the quarters ended March 28, 2020 and March 30, 2019 a total of 59,000 and 79,000There were no stock options respectively, were granted to employeesor issued under the Company’s 2020 Equity Incentive Plan and 2009 Stock Incentive Plan, respectively (collectively the “Plan”) and a total of 60,000 and 45,000 stock options, respectively, were granted to outside directors during the quarters ended March 28,September 26, 2020 and March 30, 2019September 28, 2019.
During the quarter ended MarchSeptember 26, 2020, 288,250 options were exercised at a weighted average price of $1.53, and 261,355 options expired at a weighted average price of $1.53. Also, during the quarter 500 shares were gifted to an employee for completing 20 years of service to the company. During the quarter ended September 28, 2019, 24,000 options were forfeited and 16,000 options expired.
During the quarter ended September 26, 2020 the Company repurchased 200,018 shares for employees to facilitate their exercise of stock options. During the quarter ended September 28, 2019 there were no shares issuedrepurchased.
During the three and duringnine months ended September 26, 2020 the quarterCompany recognized approximately $17 thousand and $100 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.
During the three and nine months ended March 30,September 28, 2019 there were 1,500 shares issued. the Company recognized approximately $28 thousand and $113 thousand, respectively as share-based compensation expense related to share and option grants. These amounts are included as a component of selling, general and administrative expenses in the statement of operations.
As of March 28,September 26, 2020, there was $198$163 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 1.471.79 years.
During the quarters ended March 28, There were also 1,286,500 shares outstanding at a weighted average price of $1.81 with a weighted average remaining term of 5.35 years, and there were 1,022,400 shares exercisable at a weighted average price of $1.88 with a weighted average remaining term of 4.66 years. The Plan, as amended, is authorized to issue 3,000,000 shares of common stock. As of September 26, 2020, and March 30, 2019, the Company recognized approximately $66 thousand and $59 thousand, respectively, as shared-based compensation expense related to previously grantedthere were 1,392,350 shares under the Plan.
available for future grants
(6) Inventories
Inventories consist of the following:
March 28, | December 28, | |||||||
2020 | 2019 | |||||||
Raw materials | $ | 818,501 | $ | 778,409 | ||||
Work in process | 2,005,211 | 1,898,916 | ||||||
Finished goods | 1,220,988 | 871,861 | ||||||
Gross inventory | 4,044,700 | 3,549,186 | ||||||
Reserve for obsolescence | (449,362) | (449,362) | ||||||
Inventories, net | $ | 3,595,338 | $ | 3,099,824 |
September 26, | December 28, | |||||||
2020 | 2019 | |||||||
Raw materials | $ | 968,182 | $ | 778,409 | ||||
Work in process | 1,865,505 | 1,898,916 | ||||||
Finished goods | 1,789,740 | 871,861 | ||||||
Total inventory | 4,623,427 | 3,549,186 | ||||||
Reserve for obsolescence | (436,155) | (449,362) | ||||||
Inventories, net | $ | 4,187,272 | $ | 3,099,824 |
(7) Accrued Expenses
Accrued expenses consist of the following:
September 26, | December 28, | |||||||||||||||
March 28, | December 28, | 2020 | 2019 | |||||||||||||
2020 | 2019 | |||||||||||||||
Accrued legal and accounting | $ | 28,755 | $ | 62,725 | $ | 73,171 | $ | 62,725 | ||||||||
Accrued payroll and related expenses | 508,327 | 518,015 | ||||||||||||||
Accrued payroll | 552,272 | 518,015 | ||||||||||||||
Accrued other | 154,839 | 234,426 | 94,739 | 234,426 | ||||||||||||
Total Accrued Expenses | $ | 691,921 | $ | 815,166 | ||||||||||||
$ | 720,182 | $ | 815,166 |
(8) Line of Credit
In September 2019, the Company entered into revolving line of credit with The Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million. In May of 2020 this credit line was increased to $3.0 million. The agreement includes a demand note allowing the Lender to call the loan at any time. CPS may terminate the agreement without a termination fee after 3 years. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of LIBOR plus 650 basis points. At March 28,September 26, 2020 the Company had $1.578 million$835 thousand of borrowings under this LOC and its borrowing base at the time would have permitted an additional $922 thousand$1.835 million to have been borrowed.
The line of credit is subject to certain financial covenants, all of which have been met.covenants.
(9) Note Payable
In March 2020, the company acquired a Sonoscan ultrasound microscope for a price of $208.$208 thousand. The full amount was financed through a 5 year note payable with Crest Capital Corporation. The note is collateralized by the microscope and is being paid in monthly installments of $4 thousand, consisting of principal plus interest at a rate of 6.47%.
In July 2020 CPS placed into service a piece of manufacturing equipment which it financed with the machine’s vendor. The equipment cost of $40 thousand will be paid at the rate of $2 thousand per month over 2 years, resulting in an implied interest rate of 1.90%.
The Company’s obligations including interest at September 26, 2020 consist of the following:
Remaining in: | Payments due by period | |||
FY 2020 | $ | 17,250 | ||
FY 2021 | $ | 69,000 | ||
FY 2022 | $ | 63,984 | ||
FY 2023 | $ | 48,934 | ||
FY 2024 and thereafter | $ | 57,089 | ||
Total | $ | 256,257 |
(10) Income Taxes
A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely than not" that all or a portion of deferred tax assets will not be realized. In December 2018, the Company established a valuation allowance reserve, as it is judged more likely than not that all or a portion of its deferred tax assets will not be utilized before they expire. This decision was reached after giving greater weight to the Company’s losses in recent years as compared to its forecasts.
The Coronavirus Aid, Relief and Economic Security Act (“Act”) became law on March 27, 2020. The Act contains two provisions that provide a tax benefit to the Company. The Act suspends the current 80% limitation on the utilization of net operating losses for taxable years beginning in 2018, 2019 and 2020. The Act also allows net operating losses arising in 2018, 2019 and 2020 to be carried back five years. The Act also accelerates the ability of the Company to recover Federal alternative minimum tax credits.
The Company recorded a reduction of the valuation allowance reserve of $216 thousand during the quarter ended March 28, 2020 to account for the utilization of deferred tax assets to reduce the current tax liability for the quarter ended March 28, 2020. As a result of the utilization of deferred tax assets, the Company did not record aNo provision for income taxes was provided during the quarter and nine months ended September 26, 2020, as the Company continues to maintain a full valuation allowance against the majority of its deferred tax assets and no current tax is forecasted for the quarter ended March 28, 2020. year.
ITEM 2 MANAGEMENT’SMANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with the financial statements of the Company and notes thereto included in this report and the Company’s Annual Report on Form 10-K for the year ended December 28, 2019 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.alsic.com.
2019.
Forward-Looking Statements
This Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. There are a number of factors that could cause the Company’s actual results to differ materially from those forecasted or projected in such forward-looking statements. This includes the impact of the COVID-19 pandemic, which is discussed in Item 3 of this report. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements which may be made to reflect events or changed circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Critical Accounting Policies
The critical accounting policies utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 28, 2019, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. There have been no material changes to these policies since December 28, 2019.
Overview
Products we provide include baseplates for motor controllers used in high-speed electric trains, subway cars, wind turbines, and hybrid and electric vehicles. We provide baseplates and housings used in radar, satellite and avionics applications. We provide lids and heat spreaders used with high performance integrated circuits for use in internet switches and routers. We provide baseplates and housings used in modules built with Wide Band Gap Semiconductors like SiC and GaN. CPS also assembles housings and packages for hybrid circuits. These housings and packages may include MMC components; they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.
CPS’s products are custom rather than catalog items. They are made to customers’ designs and are used as components in systems built and sold by our customers. At any point in time our product mix will consist of some products with on-going production demand, and some products which are in the prototyping or evaluation stages at our customers. The Company seeks to have a portfolio of products which include products in every stage of the technology adoption lifecycle at our customers. CPS’ growth is dependent upon the level of demand for those products already in production, as well as its success in achieving new "design wins" for future products.
The manufacturing process for MMCs (infusing ceramic materials with molten metals) is complicated and results in varying yields, which poses challenges to profitability for less developed manufacturers.
As a manufacturer of highly technical and custom products, the Company incurs fixed costs needed to support the business, but which do not vary significantly with changes in sales volume. These costs include the fixed costs of applications engineering, tooling design and fabrication, process engineering, etc. Accordingly, particularly given our current size, changes in sales volume generally result in even greater changes in financial performance on a percentage basis as fixed costs are spread over a larger or smaller base. Sales volume is therefore a key financial metric used by management.
The Company believes the underlying demand for metal matrix composites is growing as the electronics and other industries seek higher performance, higher reliability, and reduced costs. CPS believes that the Company is well positioned to offer our solutions to current and new customers as these demands grow.
Our products are manufactured by proprietary processes we have developed including the QuicksetTM Injection Molding Process (‘Quickset Process’) and the QuickCastTM Pressure Infiltration Process (‘QuickCast Process’).
CPS was incorporated in Massachusetts in 1984 as Ceramics Process Systems Corporation and reincorporated in Delaware in April 1987 through a merger into a wholly-owned Delaware subsidiary organized for purposes of the reincorporation. In July 1987, CPS completed our initial public offering of 1.5 million shares of our Common Stock. In March 2007, we changed our name from Ceramics Process Systems Corporation to CPS Technologies Corporation.
COVID-19 Pandemic
As a provider of “essential services”, CPS continues to be open and operating during the novel coronavirus pandemic. To date most of our customers remain open and operational. In Q3 we saw a significant increased volatility on the part of some of our customers, while for others it has been business as usual. We expect that this volatility will continue for at least the next several quarters. Unexpected reductions in demand on the part of two of our major customers led to a reduction in third quarter revenue. As these reductions were unexpected, by both CPS and our customers, inventory built to meet expected Q3 demand remains in inventory. We expect this inventory will be reduced over time, but will probably remain somewhat inflated over the next quarter or two.
CPS continues to follow CDC and OSHA guidance in our workplace. Employees’ temperatures are taken at the beginning of each shift, shift have been staggered to reduce employee overlap, workstations have been rearranged to ensure social distancing, all employees are using facemasks, et. The pandemic has had very little impact on our ability to produce and ship customer orders.
Results of Operations for the Third Fiscal Quarter of 2020 (Q3 2020) Compared to the Third Fiscal Quarter of 2019 (Q3 2019); (all $ in 000s)
Total revenue was $4,452 in Q3 2020, a 1% increase compared with total revenue of $4,387 in Q3 2019. This increase was due primarily to price increases of 6% offset by a reduction in sales volume of 5%. These price changes were implemented in Q4 2019 and Q1 2020. In addition, the company was able to offset a $120 thousand reserve, increasing revenue, set up for potential quality issues at one customer. This was a negotiated settlement against that customer’s reduction in purchases below the amount of their contractual obligation.
Gross margin in Q3 2020 totaled $938 or 21% of sales. In Q3 2019, gross margin was $223 or 5% of sales. This increase in margin was due to product mix, the aforementioned price increases, and increased operating efficiencies.
Selling, general and administrative expenses (SG&A) were $684 in Q3 2020, down 3% when compared with SG&A expenses of $702 in Q3 2019. This decrease was primarily due to reduced travel as a result of the Covid-19 pandemic.
In Q3, 2020, the Company incurred interest expense of $21 due primarily to bank borrowings. This compares with interest expense of $17 in Q3 of 2019.
The Company generated operating income of $253 compared with an operating loss of $479 in the same quarter last year. This increase in operating income is due primarily to the increase in pricing, discussed above. The net income for Q3 2020 totaled $231 versus a net loss of $496 in Q3 2019.
Results of Operations for the First Fiscal QuarterNine Months of 2020 (Q1 2020) Compared to the First Fiscal QuarterNine Months of 2019 (Q1 2019); (all $ in 000’s)000s)
Revenues totaled $6,512Total revenue was $16,722 in Q1the first nine months of 2020, a 4% increase compared with total revenue of $16,024 in the first nine months of 2019. This increase was due primarily to a 10% increase in pricing during the first nine months of 2020 compared with $5,270 generated in Q1 2019, an increasethe first nine months of 24%. About one third of this increase was due to increased unit volume with the balance due to price changes in Q1 2020 compared with Q1 2019.
Gross margin in Q1the first nine months of 2020 totaled $1,550$3,671 or 24%22% of sales. In the first nine months of 2019 gross margin totaled $1,557 or 10% of sales. This compares with gross margin in Q1 2019 of $159 or 3% of sales. Increases in sales volume as well as a reduction in manufacturing expenses of $202 predominantly account for this change. As stated above, the sales increase was the result ofdue to price increases, a change in both unit sales volumeproduct mix and price. The increase of unit sales volume was more than offset by increased efficiencies in manufacturing resulting in the reduction in manufacturing expenses.operating efficiencies.
Selling, general and administrative (SG&A) expenses totaled $929 in Q1were $2,466 during the first nine months of 2020, down 2% compared with SG&A expenses of $904$2,523 in Q1the first nine months of 2019. Although the Company has been ableThis small decrease was primarily due to reduce sales commission rates where appropriate, this increase was due almost entirely to increased sales commissionsreduced travel as a result of increased sales.the Covid-19 pandemic.
TheDuring the first nine months of 2020, the Company experienced anincurred interest expense of $87 due primarily to bank borrowings. This compares with interest expense of $24 incurred during the first nine months of 2019.
In the first nine months of 2020 the Company generated operating profitincome of $622 in Q1 2020$1,205 compared with an operating loss of $744$966 in Q1 2019 as a result of the improved gross margin.
same period last year. The Company is part of the Defense Industrial Base and thus has been open and operating throughout the COVID-19 pandemic. The COVID-19 pandemic did not affect financial resultsnet income for the quarter ended March 28, 2020. The Company believes the pandemic will negatively affect financial results, at least modestly, in upcoming quarters.
Since the outbreakfirst nine months of the pandemic, the Company has aggressively implemented CDC guidelines2020 totaled $1,132 versus a net loss of $990 in the workplace to prevent the spreadfirst nine months of COVID-19. For example, the Company has staggered shifts to eliminate overlap at shift changes, reorganized workstations to ensure social distancing, implemented daily screening of all employees by taking employees’ temperatures, etc. Where possible, employees are working from home.2019.
Demand from customers remains strong as of today, but this demand may be reduced due to COVID-19 related factors such as government-mandated business closings, inability of our customers to obtain components from other suppliers, etc.
We are now seeing certain operating costs increasing such as freight costs. Employee absenteeism has increased due to school closings, employees caring for sick family members, etc. Increased absenteeism is causing labor inefficiencies and increased use of overtime.
Because demand has remained strong, no employees have been furloughed and employee hours have not been reduced. The Company does not currently need and is not participating in the Payroll Protection Program of the CARES Act. The Families First Coronavirus Response Act requires the Company to pay employees who are absent due to specific COVID-19 reasons, but allows the Company to recover this cost via a reduction in the Company’s portion of payroll taxes.
All of these factors combine to create a higher degree of uncertainty regarding future financial performance, however, as of today the Company believes the effect of the COVID-19 pandemic on future financial performance will be negative, but modest.
Liquidity and Capital Resources (all $ in 000’s000s unless noted)
The Company’s net cash and cash equivalents at March 28,September 26, 2020 totaled ($1,455). (Net$113. The Company’s net cash, is defined as cash and cash equivalents lesswhich considers the $835 of bank borrowings.)borrowings, totaled a negative $722 at the end of the third quarter. This compares to cash and cash equivalents at December 28, 2019 of ($1,116). Payment terms for customers range from payment in advance to 90 days from shipment$134 and are based on factors such as credit worthiness, volumea net cash of business, etc.negative $1,116. The decreaseincrease in net cash was due primarily to longer terms for our large customers, including the elimination of the prompt pay discount, resulting inincome from operations offset by an increase in working capital (i.e. receivables and inventory less payables and accruals).capital.
Accounts receivable at March 28,September 26, 2020 totaled $5,959$3,962 compared with $4,087 at December 28, 2019.
Days Sales Outstanding (DSO) increased from 67 days at the end of 2019 to 7780 days at the end of Q1Q3 2020. The increase in DSO was due to higher salesDSO’s at the end of the quarter2019 were due to low sales during Q4 2019 to our European customers having extended payment terms compared to the beginning of the quarter, as well as higher sales to one customer with longer payment terms.in Q3 2020. The accounts receivable balances at December 28, 2019, and March 28,September 26, 2020 were both net of an allowance for doubtful accounts of $10.
Inventories totaled $3,595$4,187 at March 28,September 26, 2020 compared with inventory totaling $3,100 at December 28, 2019. This increase was a result of an inventory build up due to expected increase in customer sales volume in Q3. Unexpectedly reduced demand by their customers caused them to reduce their buying from CPS. The inventory turnover in the most recent four quarters ending Q1Q3 2020 was 6.04.9 times, (based on a 5 point average) compared withdown from 6.2 times averaged during the four quarters of 2019. 2019 (based on a 5 point average).
The Company financed its increase in working capital in Q1during the first nine months of 2020 from a combination of its net profit during the period and increased borrowings of $328 from its line of credit with BDC Capital.bank borrowings. The Company expects it will continue to be able to fund its operationsworking capital requirements for the remainder of 2020 from existing cash balances and bank borrowings.
The Company continues to sell to a limited number of customers and the loss of any one of these customers could cause the Company to require additional external financing. Failure to generate sufficient revenues, raise additional capital or reduce certain discretionary spending could have a material adverse effect on the Company’s ability to achieve its business objectives.
Contractual Obligations (all $ in 000’s unless otherwise noted)
In September 2019, the Company entered into revolving line of credit (LOC) with Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million. This agreement replaceswas amended in May 2020 to increase the $1.25 million line of credit with Santander Bank.to $3.0 million. The agreement includes a demand note allowing the Lender to call the loan at any time. The Company may terminate the agreement without a termination fee after 3 years. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of LIBOR plus 650 basis points. At March 28,September 26, 2020 the Company had $1.58 million$835 thousand of borrowings under this LOC and its borrowing base at the time would have permitted an additional $922 thousand$1.835 million to have been borrowed. The increased availability has allowed the Company to end its policy of allowing prompt pay discounts to certain customers. This has and should continue to have a positive effect on the Company’s earnings going forward.
In March 2020, the company acquired a Sonoscanan ultrasound microscope for a price of $208. The full amount was financed through a 5 year note payable with Crest Capital Corporation.a financing company. The note is collateralized by the microscope and is being paid in monthly installments of $4, consisting of principal plus interest at a rate of 6.47%
In July 2020 CPS placed into service a piece of manufacturing equipment which it financed through a capital lease with the machine’s vendor. The original lease amount was $40 thousand and will be paid at the rate of $2 thousand per month over 2 years with an interest rate of 1.9%.
As of March, 28September 26, 2020, the Company had $287$127 of construction in progress and no outstanding commitments to purchase production equipment.
The Company has two real estate leases—one expiring in February 2021 and one with an 11 month duration with options to extend additional years.expiring December 31, 2020. Since the latter is not reasonably certain that any options willexpected to be exercised,renewed, it has not been recorded on the balance sheet. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these have been capitalized. (Note 4, Leases)
Management believes that a combination of existing cash balances and borrowings, if necessary, will be sufficient to fund our cash requirements for the foreseeable future. However, there is no assurance that we will be able to generate sufficient revenues or reduce certain discretionary spending in the event that planned operational goals are not met such that we will be able to meet our obligations as they become due.
ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company is not significantly exposed to the impact of interest rate changes or foreign currency fluctuations. The Company has not used derivative financial instruments.
The COVID-19 pandemic presents several risks for the Company. The Company is part of the Defense Industrial Base and thus has remained open and operating throughout the pandemic. The primary risks resulting from the pandemic are potential declines in customer demand due to government-mandated business closures and increased operating costs resulting from pandemic-related factors such as increased freight costs and increased employee absenteeism causing labor inefficiencies and increased use of overtime.
The COVID-19 pandemic did not materially affect financial results for the quarter ended March 28, 2020. The Company believes it will negatively affect financial results, at least modestly, in upcoming quarters, due to the risks described above.
ITEM 4 CONTROLS AND PROCEDURES
(a) The Company’s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-14(c) and 15d - 14(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Form 10-Q (the “Evaluation Date”). Based on such evaluation, such officers have concluded that, as of the Evaluation Date, 1) the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports the Company files under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and 2) the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, to allow timely decisions regarding required disclosure.
(b) Changes in Internal Controls. There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.
PART II OTHER INFORMATION
ITEM 1 LEGAL PROCEEDINGS
None.
ITEM 1A RISK FACTORS
There have been no material changes to the risk factors as discussed in our 2019 Form 10-K.10-K
ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
None.
ITEM 3 DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4 MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5 OTHER INFORMATION
Not applicable.
ITEM 6 EXHIBITS AND REPORTS ON FORM 8-K:
(a) Exhibits:
Exhibit 31.1 Certification Ofof Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 Ofof The Sarbanes-Oxley Act Of 2002
Exhibit 31.2 Certification Ofof Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 Ofof The Sarbanes-Oxley Act Of 2002
Exhibit 32.1 Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Ofof 2002
(b)Reports on Form 8-K:8-K
On March 5, 2020 the Company filed a report on Form 8-K relating to the announcement of its financial results for the year ended December 28, 2019 as presented in a press release dated March 4, 2020. None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CPS TECHNOLOGIES CORPORATION
(Registrant)
Date: May 12,November 10, 2020
/s/ Grant C. Bennett
Grant C. Bennett
Chief Executive Officer
Date: May 12,November 10, 2020
/s/ Charles K. Griffith Jr.
Charles K. Griffith Jr.
Chief Financial Officer